About Us

Kamil Insights: A Decision-Support Partner, Constantly Working to Discover the Most Recent and Strategic Market Insights

Kamil Insights offer highly professional business support, through a wide selection of strategic services to the life science sector. Our high-quality service relies on proven business and commercial experience. Our creative thinking, alongside a profound market understanding with invaluable market insights, support our customers in handling complex industry challenges and business decision making.

We have a proven track record of adding value to our customers.

We have a diverse customer base, including global multinational large pharmaceutical companies, leading global API manufacturers, leading local medical device and pharmaceutical companies, incubators, accelerators, publicly traded, government and private companies.

Our services include:

  • Portfolio strategy
  • Pipeline management
  • Commercial assessment
  • Financial modeling
  • Other business and commercial services.


Go to Our Services


Liora Kamil – Business Consulting, Commercial Assessment, Market Research


Mrs. Liora Kamil is a seasoned industry professional, who has honed diverse and profound business skills at a world leading pharmaceutical company. Liora’s vast industry knowledge encompasses the realm of the life sciences industry segments including: medical devices, pharmaceuticals, diagnostics, medical imaging and biotechnology.


Liora founded Kamil Insights in 2011. Since then, she has immersed herself in business consulting and interconnecting business development services, across the life science landscape.

Prior to founding Kamil Insights, Liora held a decade long thriving pharmaceutical tenure, as an executive at Teva Pharmaceutical Industries. Liora’s responsibilities at Teva included an array of managerial positions in the innovative and generic subsidiaries, and a line of commercial responsibilities: Director of Product Strategy, Senior Manager of Marketing & Commercial Assessment, leading the commercial assessment activity in Teva’s branded product business (GBP) and heading a financial unit.


Liora Kamil holds a BA in Economics and Business Administration from the Hebrew University, Jerusalem and an MBA from the Hebrew University School of Business Administration.